Could Aiforia practically already be a partner of Roche and Agilent through those companies’ acquisitions? Assuming those deals actually cross the finish line. How do the patents work again, and what kind of agreements does/did Aiforia have? Admittedly, Aiforia is in an interesting situation.
They need to generate revenue or they’ll run out of cash, but will the backers lose faith?
6 Likes